|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
Q4 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Current assets: | |||||||||||||||
| Cash and cash equivalents | |||||||||||||||
| Accounts receivable, net allowance for credit losses | |||||||||||||||
| Deferred contract costs | |||||||||||||||
| Prepaid expenses | |||||||||||||||
| Other current assets | |||||||||||||||
| Current assets before funds held for clients | |||||||||||||||
| Funds held for clients | |||||||||||||||
| Total current assets | |||||||||||||||
| Property and equipment, net | |||||||||||||||
| Operating lease right-of-use assets | |||||||||||||||
| Goodwill | |||||||||||||||
| Intangible assets, net | |||||||||||||||
| Capitalized software, net | |||||||||||||||
| Long-term deferred contract costs | |||||||||||||||
| Other long-term assets | |||||||||||||||
| Total assets | |||||||||||||||
| Liabilities and Stockholders' Equity | |||||||||||||||
| Current liabilities: | |||||||||||||||
| Accounts payable | |||||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||||
| Accrued payroll and payroll related expenses | |||||||||||||||
| Deferred revenue | |||||||||||||||
| Current portion of long-term debt | |||||||||||||||
| Current liabilities before client fund obligations | |||||||||||||||
| Client fund obligations | |||||||||||||||
| Total current liabilities | |||||||||||||||
| Deferred income taxes | |||||||||||||||
| Long-term operating leases | |||||||||||||||
| Other long-term liabilities | |||||||||||||||
| Long-term debt, net | |||||||||||||||
| Total liabilities | |||||||||||||||
| Redeemable noncontrolling interest | |||||||||||||||
| Stockholders' equity: | |||||||||||||||
| Common stock $0.001 par value per share, 500,000,000 shares authorized, 181,251,037 shares outstanding at December 31, 2024 and 178,210,263 shares outstanding at June 30, 2024 | |||||||||||||||
| Treasury stock, at cost, 10,620,260 shares at March 31, 2023 and June 30, 2022 | |||||||||||||||
| Treasury stock, at cost, 10,620,260 shares at December 31, 2024 and June 30, 2024 | |||||||||||||||
| Preferred stock, $0.001 par value, 50,000,000 shares authorized, — shares outstanding at December 31, 2024 and June 30, 2024 | |||||||||||||||
| Preferred Stock | |||||||||||||||
| Series A Preferred Stock | |||||||||||||||
| Total preferred stock, $0.001 par value, 50,000,000 shares authorized, — shares outstanding at December 31, 2024 and June 30, 2024 | |||||||||||||||
| Additional paid-in capital | |||||||||||||||
| Accumulated deficit | |||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||
| Total stockholders' equity | |||||||||||||||
| Total liabilities and stockholders' equity | |||||||||||||||
| Preferred stock, shares authorized (in shares) | |||||||||||||||
| Preferred Stock | |||||||||||||||
| Series A Preferred Stock | |||||||||||||||
| Total preferred stock, shares authorized (in shares) | |||||||||||||||
| Preferred stock, par value (in dollars per share) | |||||||||||||||
| Preferred Stock | |||||||||||||||
| Series A Preferred Stock | |||||||||||||||
| Total preferred stock, par value (in dollars per share) | |||||||||||||||
Loading...